A Multi-Institutional Phase II Trial of Preoperative Full-Dose Gemcitabine and Concurrent Radiation for Patients With Potentially Resectable Pancreatic Carcinoma

Freedman, Gary M.; Zalupski, Mark M.; Small, William; Mulcahy, Mary F.; Hoffman, John P.; McGinn, Cornelius J.; Colletti, Lisa M.; Wayne, Jeffrey D.; Attaluri, Vikram; Kinsella, Timothy J.; Philip, Philip A.; Talamonti, Mark S.

2006-02

Citation: Talamonti, Mark S.; Small, William; Mulcahy, Mary F.; Wayne, Jeffrey D.; Attaluri, Vikram; Colletti, Lisa M.; Zalupski, Mark M.; Hoffman, John P.; Freedman, Gary M.; Kinsella, Timothy J.; Philip, Philip A.; McGinn, Cornelius J.; (2006). "A Multi-Institutional Phase II Trial of Preoperative Full-Dose Gemcitabine and Concurrent Radiation for Patients With Potentially Resectable Pancreatic Carcinoma." Annals of Surgical Oncology 13 (2): 150-158. <http://hdl.handle.net/2027.42/41411>

Abstract: We report the results of a multi-institutional phase II trial that used preoperative full-dose gemcitabine and radiotherapy for patients with potentially resectable pancreatic carcinoma.

ISSN: 1534-4681, 1068-9265

DOIs: http://dx.doi.org/10.1245/ASO.2006.03.039

PMID: 16418882

URI: http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=16418882&dopt=citation

Handle: http://hdl.handle.net/2027.42/41411

Show full item record